An integrated ’omics approach highlights the role of epigenetic events to explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer

ABSTRACT: DNA methylation profiling (Illumina Infinium 450K) was performed on fresh frozen tumor biopsies taken before, during and after treatment from patients receiving neoadjuvant chemotherapy with or without the anti-angiogenic drug bevacizumab

ORGANISM(S): Homo sapiens

PROVIDER: GSE207460 | GEO | 2024/07/01

REPOSITORIES: GEO